omniture
和其瑞医药(南京)有限公司 Heqirui Pharmaceutical (Nanjing) Co. LTD

Latest News

Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis

SHANGHAI, March 24, 2026 /PRNewswire/ -- Hope Medicine Inc., a science-driven, clinical-stage innov...

2026-03-25 08:08 3880

Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development

HMI-115 received FDA Fast Track Designation based on results from a Phase II clinical trial for end...

2025-12-04 20:08 3556

Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment

HMI-115 demonstrated statistically significant improvement in endometriosis pain The mean dysmenorr...

2025-10-08 09:08 2490

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation

HMI-115 has demonstrated statistically significant improvement in endometriosis pain The mean dysm...

2024-10-24 08:08 5107

Positive Outcome from a Phase Ib Study in Australia Treating Patients with Androgenic Alopecia

SHANGHAI, Jan. 14, 2024 /PRNewswire/ -- Hope Medicine Inc. ('HopeMed'), a clinical-stage innovative...

2024-01-15 08:08 2933

Hope Medicine Announces US FDA Clearance for Phase II Clinical Trial of A First-in-class Monoclonal Antibody, HMI-115, in Androgen Alopecia

SHANGHAI, Jan. 25, 2022 /PRNewswire/ -- Hope Medicine Inc. ('HopeMed'), a clinical stage innovative...

2022-01-26 08:00 2838

Hope Medicine Inc. Announced Dr. Henri Nico Doods as Chief Executive Officer

SHANGHAI, Aug. 30, 2021 /PRNewswire/ -- Hope Medicine Inc. ('HopeMed'), a clinical stage innovative...

2021-08-30 08:00 7757

Hope Medicine completed US$56 million in Series B financing, strengthening capabilities of global innovation

SHANGHAI, May 6, 2021 /PRNewswire/ -- Recently, the global innovative drug R&D company Hope Medicin...

2021-05-06 08:00 8349